Related references
Note: Only part of the references are listed.Treatment Responsiveness in KCNT1-Related Epilepsy
Mark P. Fitzgerald et al.
NEUROTHERAPEUTICS (2019)
A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures
Priyanka Madaan et al.
BRAIN & DEVELOPMENT (2018)
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy
Robertino Dilena et al.
NEUROTHERAPEUTICS (2018)
Lack of response to quinidine in KCNT1-related neonatal epilepsy
Adam L. Numis et al.
EPILEPSIA (2018)
Quinidine therapy for West syndrome with KCNTI mutation: A case report
Masataka Fukuoka et al.
BRAIN & DEVELOPMENT (2017)
Ineffective Quinidine Therapy in Early Onset Epileptic Encephalopathy With KCNT1 Mutation
Pin Fee Chong et al.
ANNALS OF NEUROLOGY (2016)
KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects
Chiao Xin Lim et al.
JOURNAL OF MEDICAL GENETICS (2016)
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy
Francesca Rizzo et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Quinidine in the Treatment of KCNT1-Positive Epilepsies
Mohamad A. Mikati et al.
ANNALS OF NEUROLOGY (2015)
Topiramate in monotherapy or in combination as a cause of metabolic acidosis in adults with epilepsy
Velvet J. Ruiz-Granados et al.
REVISTA DE NEUROLOGIA (2015)
Targeted Treatment of Migrating Partial Seizures of Infancy with Quinidine
David Bearden et al.
ANNALS OF NEUROLOGY (2014)
KCNT1 Gain of Function in 2 Epilepsy Phenotypes is Reversed by Quinidine
Carol J. Milligan et al.
ANNALS OF NEUROLOGY (2014)
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yaping Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Identification of a Novel de Novo p.Phe932lle KCNT1 Mutation in a Patient With Leukoencephalopathy and Severe Epilepsy
Adeline Vanderver et al.
PEDIATRIC NEUROLOGY (2014)
Increased drug delivery to the brain by P-glycoprotein inhibition
AJM Sadeque et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
